1. Solomon S. Philip Morris investment in Syqe was 2nd-largest 2016 cannabis deal – report. The Times of Israel. January 9, 2017. Accessed January 3, 2023. https://www.timesofisrael.com/philip-morris-investment-in-syqe-was-2nd-largest-2016-cannabis-deal-report/
2. Kollewe J, Davies R. Inhaler firm Vectura removed from conference over Philip Morris takeover. The Guardian. September 16, 2021. Accessed January 3, 2023. https://www.theguardian.com/business/2021/sep/16/tobacco-philip-morris-takeover-uk-inhaler-vectura-health
3. Philip Morris International Acquires Inhaled Drug Specialist OtiTopic; Growing Pipeline of “Beyond Nicotine” Inhaled Therapeutic Products: PMI’s expertise and Beyond Nicotine portfolio companies to speed ASPRIHALE® to market. Businesswire. August 9, 2021. Accessed January 3, 2023. https://www.businesswire.com/news/home/20210809005323/en/Philip-Morris-International-Acquires-Inhaled-Drug-Specialist-OtiTopic-Growing-Pipeline-of-%E2%80%9CBeyond-Nicotine%E2%80%9D-Inhaled-Therapeutic-Products
4. Fertin Pharma and associated companies acquired by Philip Morris International. Fertin Pharma. July 1, 2021. Accessed January 3, 2023. https://fertin.com/2021/07/01/fertin-pharma-and-associated-companies-acquired-by-philip-morris-international/
5. AG Snus Aktieselskab sold to Phillip Morris International. Mazanti — Andersen. May 7, 2021. Accessed January 3, 2023. https://www.mazanti.dk/en/news/ag-snus-aktieselskab-sold-to-phillip-morris-international/